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Abstract
Background: Dietary calcium intake and the renin angiotensin system (RAS) regulate blood pressure (BP) by modulating
calcium homeostasis. Despite similar BP regulatory effects, the influence of dietary calcium intake alone and combined
with RAS polymorphisms on the BP response following acute aerobic exercise (i.e., postexercise hypotension) has not
been studied. Thus, we examined the effect of dietary calcium intake and selected RAS polymorphisms on postexercise
hypotension.
Methods: Subjects were men (n = 50, 43.8 ± 1.3 yr) with high BP (145.3 ± 1.5/85.9 ± 1.1 mm Hg). They completed three
experiments: non-exercise control and two cycle bouts at 40% and 60% of maximal oxygen consumption (VO2max).
Subjects provided 3 d food records on five protocol-specific occasions. Dietary calcium intake was averaged and
categorized as low (<880 mg/d = LowCa) or high (≥ 880 mg/d = HighCa). RAS polymorphisms (angiotensin converting
enzyme insertion/deletion, ACE I/D; angiotensin II type 1 receptor, AT1R A/C) were analyzed with molecular methods.
Genotypes were reduced from three to two: ACE II/ID and ACE DD; or AT1R AA and AT1R CC/AC. Repeated measure
ANCOVA tested if BP differed among experiments, dietary calcium intake level and RAS polymorphisms.
Results: Systolic BP (SBP) decreased 6 mm Hg after 40% and 60% VO2max compared to non-exercise control for 10 h
with LowCa (p < 0.01), but not with HighCa (p ≥ 0.05). Under these conditions, diastolic BP (DBP) did not differ between
dietary calcium intake levels (p ≥ 0.05). With LowCa, SBP decreased after 60% VO2max versus non-exercise control for
10 h among ACE II/ID (6 mm Hg) and AT1R AA (8 mm Hg); and by 8 mm Hg after 40% VO2max among ACE DD and
AT1R CC/CA (p < 0.01). With HighCa, SBP (8 mm Hg) and DBP (4 mm Hg) decreased after 60% VO2max compared to
non-exercise control for 10 h (p < 0.05), but not after 40% VO2max (p ≥ 0.05).
Conclusion: SBP decreased after exercise compared to non-exercise control among men with low but not high dietary
calcium intake. Dietary calcium intake interacted with the ACE I/D and AT1R A/C polymorphisms to further modulate
postexercise hypotension. Interactions among dietary calcium intake, exercise intensity and RAS polymorphisms account
for some of the variability in the BP response to exercise.
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Background
Recommendations to prevent and treat hypertension
include weight loss, reduced sodium and adequate cal-
cium intake, limited alcohol consumption, consumption
of a diet rich in fruits, vegetables and low fat dairy prod-
ucts, and habitual physical activity [1]. The blood pressure
(BP) lowering effects of dietary interventions are greater
than those resulting from exercise [2,3]. Yet, the BP reduc-
tions resulting from combined nutrition and exercise life-
style therapies are less than that expected based upon the
estimated effects of either intervention used alone [3,4].
Variation in the individual BP response to lifestyle inter-
ventions as a result of interactions among environmental
and genetic factors that are complex and not easily under-
stood provides an explanation for these observations
[5,6].
Epidemiological and experimental evidence indicate that
calcium homeostasis has a role in BP regulation [8-13].
Low calcium dietary intake has been linked to higher BP
and the development of hypertension, whereas calcium
supplementation lowers BP. Ruidavets et al. [11] recently
found significant and independent associations among
higher dairy product and dietary calcium intakes and
lower BP among 912 middle aged men [systolic BP (SBP)
more so than diastolic BP (DBP)]. Dietary calcium intake
is hypothesized to regulate BP by its influence on calc-
itrophic hormones, intracellular calcium concentration
and vasculature reactivity [8-13].
The renin angiotensin system (RAS) is an important regu-
lator of cardiovascular and renal function [14-16]. The
RAS pathway begins with the production of renin that acts
on angiotensinogen to form angiotensin I. Angiotensin
converting enzyme (ACE) converts biologically inactive
angiotensin I into angiotensin II, a potent vasopressor
whose actions are mediated by the angiotensin II type 1
receptor (AT1R). These actions include mobilization of
intracellular calcium, vasoconstriction, renal sodium rea-
bsorption and aldosterone production. In population
studies genetic variants of the RAS are associated with an
increased risk of hypertension, notably the ACE insertion
deletion (ACE I/D) and AT1R A/C polymorphisms
[17,18].
Postexercise hypotension, or the immediate decrease in
BP that occurs after a bout of aerobic exercise, is an
accepted physiologic response to exercise with the largest
BP decreases seen in those with the highest resting BP
[19,20]. Yet, not all people with hypertension demon-
strate postexercise hypotension for reasons that are not
clear. We recently reported that the ACE I/D and AT1R A/
C polymorphisms explain some of the variability in the
BP response to acute aerobic exercise among men with
elevated BP [21].
Dietary calcium intake [8-13] and the RAS [14-16] are
important regulators of BP via their influence on calcium
metabolism and vascular reactivity. Low dietary calcium
intake paradoxically increases intracellular calcium con-
centration and is associated with high BP [8-13]. Angi-
otensin II regulates intracellular calcium concentration
and peripheral vascular resistance by its actions on the
AT1R [22,23]. Yet, the combined influence of dietary cal-
cium intake and RAS polymorphisms associated with
high BP on postexercise hypotension has not been stud-
ied.
The present investigation was designed to assess the
effects of dietary calcium intake alone and in combination
with the ACE I/D and AT1R A/C polymorphisms on pos-
texercise hypotension among men with elevated BP. Since
exercise induced BP reductions are greatest in those with
the highest resting BP [19,20], we hypothesized that men
consuming lower amounts of dietary calcium would expe-
rience greater BP reductions following a bout of aerobic
exercise than men consuming higher amounts of dietary
calcium. In addition, we postulated the exercise induced
BP effects associated with dietary calcium intake would be
further modulated by the ACE I/D and AT1R A/C poly-
morphisms. Consistent with our hypotheses, we found
that interactions among dietary calcium intake, exercise
intensity and RAS polymorphisms altered the BP response
to acute aerobic exercise.
Methods
Subjects
Volunteers were 50 men between 18 and 55 yr with high
normal to Stage 1 hypertension (SBP ≥ 130–159 and/or
DBP ≥ 85–99 mm Hg). Subjects completed an informed
consent approved by the Institutional Review Boards of
the University of Connecticut and Hartford Hospital. If
potential volunteers were taking medications or dietary
supplements known to influence the BP response to exer-
cise, they discontinued use for a least one month prior to
the study. During this washout period, subjects taken off
antihypertensive medications were monitored for evi-
dence of accelerated hypertension. Men with excessive
resting BP (SBP ≥ 160 and/or DBP ≥ 100 mm Hg) were
excluded from further participation.
Procedures
The study design (Figure 1) and procedures have been
described elsewhere [20,21]. Briefly, potential subjects
completed an orientation session to familiarize them with
the study, ensure their BP met the study inclusion criteria
of high normal to Stage 1 hypertension, and educate them
about the study procedures. In addition, waist circumfer-
ence was measured, and height and weight were taken on
a standard balance-beam scale (Model 339, Detecto,
Webb City, MO) to calculate body mass index (kg/m2).Nutrition & Metabolism 2007, 4:1 http://www.nutritionandmetabolism.com/content/4/1/1
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During the orientation session, participants were told to
maintain their usual diet for the duration of the study.
Prior to all testing sessions, subjects consumed a standard
pre-testing meal of 1 c of low fiber cereal or a choice of
one of the following: 2 slices of white toast, an English
muffin or a 3.5 in diameter bagel. This meal was accom-
panied by 4 oz of 2%, 1% or skim milk, and 8 oz of orange
juice. The entire meal was consumed 2 h prior to any test-
ing session. Participants were also instructed to refrain
from any caffeinated beverage the morning of all testing
sessions and to drink caffeinated and alcoholic beverages
in moderation (≤ 2 cups and drinks/d, respectively)
throughout the study.
Participants received instruction on recording 3 d dietary
records by the same registered dietitian on the mornings
of the orientation session and graded cardiopulmonary
exercise test. An example of an incomplete and a complete
dietary record were shown to subjects in addition to ver-
bal instruction on proper recording. Portion sizes were
reviewed using food models as visuals. Subjects provided
3 d dietary records on five occasions (i.e., the orientation
session, graded cardiopulmonary exercise test, and three
experiments) (Figure 1). The registered dietitian per-
formed a 24 h recall following the graded cardiopulmo-
nary exercise test to validate 3 d dietary records over the
same time period. Food records for 15 d were entered into
the Nutrition Pro software program (N-Square Comput-
ing, Salem, OR) and analyzed by the registered dietitian
for all subjects. Weight maintenance throughout the study
was also used as an indication that volunteers were adher-
ing to their usual dietary patterns. Men were weighed dur-
ing the orientation session as well as prior to the graded
cardiopulmonary exercise test and the three experiments
to monitor weight maintenance.
At the completion of the orientation session, volunteers
were attached to an ambulatory BP monitor (Accutracker
II automatic noninvasive ambulatory BP monitor, Sun-
tech Medical Instruments Inc., Raleigh, NC). The monitor
was calibrated with a mercury sphygmomanometer until
three successive measurements were within 5 mm Hg of
values made by auscultation. The monitor was pro-
grammed to record BP approximately every 20 min. All
subjects left the laboratory with instructions to proceed
with their typical daily activities except for formal exercise
and to return the monitor the following day. The compu-
terized recordings were considered acceptable if at least
80% of the BP readings were obtained via the manufac-
turer's quality control criteria. If awake ambulatory BP
averaged <135/85 mmHg, subjects were excluded from
further participation [24].
Volunteers then completed a graded cardiopulmonary
exercise test on a cycle ergometer (Monark Ergomedic
818E, Stockholm, Sweden) to determine the experimental
exercise workloads. Maximal oxygen consumption
(VO2max) was measured by breath-by-breath analysis of
expired gases via an open circuit respiratory apparatus
(Sensormedics Vmax 29 Metabolic Chart, SensorMedics
Corp., Yorba Linda, CA). At the conclusion of the graded
cardiopulmonary exercise test, volunteers were again
attached to the ambulatory BP monitor to further
acquaint them with the equipment.
Volunteers performed three 40 min experiments that were
conducted in random order, performed at the same time
of day, and were separated by a minimum of 48 h. The
experiments included a non-exercise control session of
seated rest, and two exercise bouts on a cycle ergometer
performed at low (40% VO2max) and moderate intensity
(60% VO2max) (Figure 1). All experiments began with a
20 min baseline period and were blinded to the subject
until the conclusion of the baseline period. The exercise
bouts consisted of 30 min of cycling at the designated
exercise intensity with a 5 min warm up and 5 min cool
Study design overview [20] Figure 1
Study design overview [20]. ABP = ambulatory blood 
pressure; VO2max = maximal oxygen consumption; * 3 d die-
tary record beginning the morning of each testing session and 
continued for the next 2 d; ** Blood pressure taken through-
out (see text for details); † worn until waking the next morn-
ing; ‡ includes 5 min warm-up and 5 min cool down periods 
to total 40 min of exercise.
#1 Orientation Session* 
#2 Graded Exercise Test *,** ABP Monitor **,†
ABP Monitor **,†
 40% VO2max
*,**,‡
CONTROL *,**
Seated Rest 
60% VO2max
20 min Baseline **
Seated Rest 
#3 Experimental Sessions* 
(40 min, blinded & random order)
45 min Recovery **
Seated Rest 
ABP Monitor **,†Nutrition & Metabolism 2007, 4:1 http://www.nutritionandmetabolism.com/content/4/1/1
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down to total 40 min of exercise. Experiments then con-
cluded with a 45 min recovery period of seated rest in the
laboratory. During the experiments, heart rate was meas-
ured with a heart rate monitor (Model # 1902750, Polar
Electro Inc, Woodbury, NY), and BP by auscultation by
the same study investigator for every subject. Subjects left
the laboratory wearing an ambulatory BP monitor until
the next morning. The average hook up time to the ambu-
latory BP monitor was 12:30 pm.
Genotype analysis
DNA was isolated from anticoagulated EDTA blood sam-
ples and typed for common RAS genetic variations. DNA
was purified with molecular methods using the Pure-
gene™ DNA Isolation Kit (Gentra systems, Inc. Minneapo-
lis, MN). Separate primers that have been described
elsewhere were used to detect RAS polymorphisms by the
polymerase chain reaction and the restriction fragment
length polymorphism method to determine mutations in
the ACE I/D [25] and AT1R A/C [26] genes.
Statistical analyses
A mean replacement strategy was used to replace the small
number of missing BP values, and ambulatory BP values
were then averaged at hourly intervals for purposes of sta-
tistical analyses. BP results are reported for 10 h after all
experimental conditions because this is the time period
over which subjects were awake and ambulating [20].
Descriptive statistics were generated on all study variables.
Independent t-tests indicated that the 24 h food recall
analysis following the graded cardiopulmonary exercise
test did not differ from the analysis generated using the 3
d food records over this same time period (p ≥ 0.05).
Because repeated measures analysis of variance revealed
dietary calcium intake did not differ among the five mon-
itoring periods (p ≥ 0.05), dietary calcium intake was aver-
aged for 15 d and categorized by the sample median as
LowCa (<880 mg/d, n = 25) or HighCa (≥ 880 mg/d, n =
25). The Chi-Square test was used to establish any devia-
tion from the Hardy-Weinberg equilibrium among the
RAS polymorphisms in the total sample and by dietary
calcium intake level. Independent t-tests determined if
physical characteristics and nutrient intake differed
between dietary calcium intake level and RAS polymor-
phisms.
Repeated measures analysis of covariance tested if BP dif-
fered over time within and among experimental condi-
tions (non-exercise control, 40% VO2max and 60%
VO2max) and dietary calcium intake level (LowCa and
HighCa). The ACE I/D (n = 49) and AT1R (n = 48) poly-
morphisms were distributed in accordance with the
Hardy-Weinberg equilibrium having frequencies of ACE
II 24%, ID 40% and DD 36% and AT1R AA of 56%, AC
40% and CC 4% in the total sample. Similarly, RAS poly-
morphisms were in Hardy-Weinberg equilibrium in the
LowCa and HighCa groups. We previously found no sig-
nificant differences in the BP responses among carriers of
the I allele of the ACE I/D and the C allele of the AT1R A/
C polymorphisms [21]. These genotypes were combined
reducing the number of genotype classes in each RAS pol-
ymorphism from three to two (i.e., ACE II/ID and DD;
and AT1R AA and CC/AC).
Repeated measures analysis of covariance then tested if BP
differed over time within and among experimental condi-
tions (non-exercise control, 40% VO2max and 60%
VO2max), dietary calcium intake level (LowCa and
HighCa), and the combined RAS genotype groups (ACE
II/ID and DD; or AT1R AA and CC/AC). Covariates
entered singularly in these analyses included average die-
tary intake of sodium, potassium, and magnesium; daily
energy intake; % of total calcium derived from dairy
sources; age; body mass index; and waist circumference.
None of these covariates altered the primary BP outcomes
found with dietary calcium intake level alone and with
RAS polymorphisms so that unadjusted BP data are pre-
sented. All statistical analyses were performed with the
Statistical Package for Social Sciences Base 14.0 (SPSS Inc.,
Chicago, IL) for Windows with p < 0.05 established as the
level of significance.
Results
Subjects
Subjects (n = 50) were middle-aged, Caucasian men with
elevated BP (Table 1). They were overweight and had
below average physical fitness for men of their age [27].
Subjects with LowCa had higher awake ambulatory DBP
and were older than those with HighCa (p < 0.05), while
all other physical characteristics were not different
between dietary calcium intake levels (p ≥ 0.05). In addi-
tion, physical characteristics were not different among the
RAS polymorphisms (data not shown) (p ≥ 0.05).
Dietary nutrient intake
Subjects consumed an average of 2577 ± 97 kcal/d of
which 49% was from carbohydrates, 33% from total fat,
13% from saturated fat and 16% from protein (Table 2).
Percent energy from saturated fat and average sodium
intake exceeded current recommendations, and average
magnesium intake was below recommended levels. All
other nutrients were within recommended ranges [28].
Subjects generally consumed alcohol and caffeine (i.e.,
coffee) in moderate amounts of one to two glasses or cups
per day, respectively. Men in the LowCa group consumed
significantly less calcium, sodium, potassium, magne-
sium and daily calories than men in the HighCa group (p
< 0.01) (Table 2). Dairy products provided 50% of total
calcium intake. Subjects in the LowCa group had a lower
percentage of calcium intake from dairy sources than menNutrition & Metabolism 2007, 4:1 http://www.nutritionandmetabolism.com/content/4/1/1
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in the HighCa group, 45% versus 54%, respectively (p <
0.05). Other sources of calcium included daily multivita-
mins and fortified foods such as orange juice, cereal and
enriched bread.
BP response
The BP findings following the experimental conditions
(non-exercise control, 40% VO2max and 60% VO2max)
in the total sample have been published [20]. They are
briefly summarized for purposes of reference. SBP
increased and DBP decreased after all experimental condi-
tions compared to pre-experiment baseline values over 10
h (p < 0.001). However, SBP was reduced by 4.7 mm Hg
after 60% VO2max and 2.4 mm Hg after 40% VO2max,
and DBP was lower by 1.4 mm Hg after 40% VO2max
only compared to non-exercise control over 10 h (p <
0.05).
BP response by dietary calcium level
SBP was reduced by approximately 6 mm Hg after exercise
(40% and 60% VO2max) compared to non-exercise con-
trol for 10 h with LowCa (p < 0.01), but not HighCa (p ≥
0.05) (Figure 2). Under these experimental conditions,
DBP was not different between dietary calcium intake lev-
els (p ≥ 0.05) (Figure 3).
We then determined whether the SBP reductions we
found between exercise and non-exercise control with
LowCa differed between dietary calcium levels for a given
exercise condition (40% or 60% VO2max). The SBP
response after 40% VO2max (a 6.0 mm Hg decrease versus
a 1.4 mm Hg increase) compared to non-exercise control
differed between LowCa and HighCa, respectively (p ≤
0.05), but not after 60% VO2max (5.6 versus 3.7 mm Hg)
(p ≥ 0.05).
BP response by dietary calcium level and RAS 
polymorphisms
Low calcium dietary intake
ACE I/D polymorphism
Among carriers of the ACE I allele (i.e., ACE II/ID), SBP
was reduced by 5.7 mm Hg from a pre-experiment base-
line SBP of 126.6 ± 3.5 mm Hg after 60% VO2max com-
pared to non-exercise control for 10 h (p < 0.01) (Table
3). Among ACE DD homozygotes, SBP tended to be lower
by 9.8 mm Hg from a baseline SBP of 131.3 ± 5.6 mm Hg
Table 2: Mean (± SEM) nutrient intake of study sample and by dietary calcium intake level.
Nutrient Total Sample (n = 50) Low Calcium (n = 25) High Calcium (n = 25)
Calcium (mg/d) 1019.9 ± 76.2 659.4 ± 28.6‡ 1380.4 ± 109.8
Energy Intake (kcal/d) 2576.8 ± 97.4 2224.0 ± 92.2‡ 2929.5 ± 97.4
Carbohydrate (% kcal/d) 49.4 ± 1.0 48.5 ± 1.3 50.4 ± 1.5
Fat (% kcal/d) 33.2 ± 0.9 34.2 ± 1.3 32.2 ± 1.2
Saturated Fat (% kcal/d) 13.0 ± 0.4 12.9 ± 0.5 13.0 ± 0.7
Protein (% kcal/d) 15.5 ± 0.3 15.5 ± 0.5 15.5 ± 0.4
Sodium (mg) 4010.8 ± 395.0 3400.5 ± 183.8† 4621.0 ± 395.0
Potassium (mg) 2920.2 ± 126.8 2551.5 ± 111.0† 3288.9 ± 2.5.0
Magnesium (mg) 293.1 ± 15.3 249.1 ± 12.5† 337.2 ± 25.3
Alcohol (gm) 12.7 ± 2.4 12.1 ± 2.7 13.3 ± 3.9
Caffeine (mg) 141.6 ± 18.7 150.5 ± 22.3 132.7 ± 30.4
†p < 0.01, ‡p < 0.001 low (<median) versus high (≥ median) dietary calcium intake
Table 1: Mean physical characteristics (± SEM) of the study sample (n = 50) and by dietary calcium intake level.
Characteristics Total 
(n = 50)
Low Calcium 
(n = 25)
High Calcium 
(n = 25)
Age (yr) 43.8 ± 1.3 47.1 ± 1.2* 40.5 ± 2.3
Body mass index (kg/m2) 29.4 ± 0.7 28.6 ± 0.1 30.3 ± 1.2
Waist Circumference (cm) 101.9 ± 2.0 99.0 ± 2.4 104.2 ± 2.9
24 h Ambulatory SBP (mmHg) 141.4 ± 1.5 140.6 ± 2.2 142.2 ± 2.8
24 h Ambulatory DBP (mmHg) 83.3 ± 1.0 85.1 ± 1.5 81.5 ± 1.3
Ambulatory Awake SBP (mmHg) 145.3 ± 1.5 145.3 ± 2.4 145.3 ± 1.9
Ambulatory Awake DBP (mmHg) 85.9 ± 1.0 88.1 ± 1.6* 83.8 ± 1.3
Relative Maximum VO2 (ml·kg-
1min-1)
31.3 ± 0.9 30.9 ± 1.1 31.7 ± 1.5
SBP = systolic blood pressure, DBP = diastolic blood pressure; VO2 = oxygen consumption
* p < 0.05 low (< median) versus high (≥ median) dietary calcium intakeNutrition & Metabolism 2007, 4:1 http://www.nutritionandmetabolism.com/content/4/1/1
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after 40% VO2max than non-exercise control for 10 h (p =
0.058). Under these conditions, DBP response was not
different among the ACE I/D genotype groups (p ≥ 0.05).
We then examined whether the SBP reductions we found
between exercise and non-exercise control within the ACE
I/D genotype groups differed between genotype groups
for a given exercise condition. The SBP reductions after
40% VO2max (3.5 versus 9.8 mm Hg) and 60% VO2max
(5.7 versus 2.6 mm Hg) compared to non-exercise control
differed between the ACE II/ID and DD genotype groups,
respectively (p ≤ 0.05).
AT1R A/C polymorphism
Among AT1R AA homozygotes, SBP was reduced by 7.5
mm Hg from a pre-experiment baseline SBP of 127.8 ± 3.8
mm Hg after 60% VO2max compared to non-exercise con-
trol (p < 0.01) (Table 4). Among carriers of the AT1R C
allele (i.e., AT1R AC/CC), SBP was lower by 7.5 mm Hg
from a baseline SBP of 127.9 ± 5.0 mm Hg after 40%
VO2max than non-exercise control for 10 h (p < 0.05).
Under these conditions, DBP was not different among the
AT1R A/C genotype groups (p ≥ 0.05). The SBP reductions
after 60% VO2max (7.5 versus 2.1 mm Hg) compared to
non-exercise control differed between the AT1R AA and
CC/AC genotype groups (p ≤ 0.05), respectively; but not
after 40% VO2max (5.2 versus 7.5 mm Hg) (p ≥ 0.05).
High calcium dietary intake
ACE I/D polymorphism
Among carriers of the ACE I allele, SBP and DBP were not
different after exercise and non-exercise control (p ≥ 0.05)
(Table 3). Among ACE DD homozygotes, SBP was
reduced by about 7.5 mm Hg from a baseline SBP of
125.1 ± 3.2 mm Hg and DBP was lower by 4.5 mm Hg
from a baseline DBP of 88.9 ± 2.6 mm Hg after 60%
VO2max compared to non-exercise control for 10 h (p <
0.05). The SBP response (a 1.2 mm Hg increase versus a
7.5 mm Hg decrease) after 60% VO2max compared to
non-exercise control differed between the ACE II/ID and
DD genotype groups, respectively (p < 0.05). Under these
conditions, there was a tendency for the DBP reductions
(0.6 versus 4.5 mm Hg) (p = 0.065) to be different
between the ACE II/ID and DD genotype groups as well.
AT1R A/C polymorphism
Among AT1R AA homozygotes, SBP was reduced by 6.9
mm Hg from a baseline SBP of 121.1 ± 3.1 mm Hg after
60% VO2max than non-exercise control for 10 h (p <
0.05) (Table 4); whereas DBP was not (p ≥ 0.05). Among
carriers of the AT1R C allele, SBP and DBP were not differ-
ent after exercise than non-exercise control for 10 h (p ≥
0.05). The SBP reductions (6.9 verus 1.2 mm Hg) after
60% VO2max compared to non-exercise control tended to
be different between the AT1R AA and CC/AC genotype
groups, respectively (p = 0.086).
Discussion
We examined the influence of dietary calcium intake on
the BP response to acute aerobic exercise among 50 Cau-
casian, middle aged and overweight men with high nor-
mal to Stage 1 hypertension. In addition, we sought to
determine if the BP response following acute endurance
exercise was altered by interactions among dietary calcium
Mean diastolic blood pressure change (± SEM) from baseline  after exercise and non-exercise control by dietary calcium  intake level for 10 h Figure 3
Mean diastolic blood pressure change (± SEM) from 
baseline after exercise and non-exercise control by 
dietary calcium intake level for 10 h. DBP = diastolic 
blood pressure; VO2max = maximal oxygen consumption; 
Low = < median dietary calcium intake; High = ≥ median die-
tary calcium intake.
0
-1
-2
-3
Mean DBP Change
Control
40% VO2max -4
60% VO2max
-5
-6
Low High Dietary Calcium Intake Level
Mean systolic blood pressure change (± SEM) from baseline  after exercise and non-exercise control by dietary calcium  intake level over 10 h Figure 2
Mean systolic blood pressure change (± SEM) from 
baseline after exercise and non-exercise control by 
dietary calcium intake level over 10 h. SBP = systolic 
blood pressure; VO2max = maximal oxygen consumption; 
Low = < median dietary calcium intake; High = ≥ median die-
tary calcium intake.
14
p<0.01 exercise vs non-exercise control Control
40% VO2max
60% VO2max 12
10
*
*
8
Mean SBP Change
† 6
4
2
0
Low High
Dietary Calcium Intake LevelNutrition & Metabolism 2007, 4:1 http://www.nutritionandmetabolism.com/content/4/1/1
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intake and two RAS polymorphisms associated with
hypertension, i.e., ACE I/D and AT1R A/C, that we [21]
and others [29] have shown alter postexercise hypoten-
sion.
The new findings from this investigation are as follows.
SBP was reduced by 6 mm Hg after exercise (40% and
60% VO2max) compared to non-exercise control over 10
h with LowCa, but not with HighCa (Figure 2). However,
Table 3: Mean blood pressure change (± SEM) from baseline after exercise and non-exercise control by ACE I/D genotype group over 
10 h (95% confidence interval).
Dietary Calcium Intake Level
Low High
Non-Exercise Control 40% VO2max 60% VO2max Non-Exercise Control 40% VO2max 60% VO2max
(n = 18) ACE II/ID (n = 13)
SBP 11.0 ± 2.0 
(7.0,15.1)
7.5 ± 1.9 
(3.8,11.3)
5.3 ± 2.2† 
(0.9,9.7)
7.5 ± 2.4 
(2.7,12.3)
13.8 ± 2.2 
(9.4,18.2)
8.7 ± 2.6 
(3.6,13.9)
DBP -0.7 ± 1.5 
(-3.9,2.4)
-3.5 ± 1.3 
(-6.1,-0.9)
-2.6 ± 1.3 
(-5.3,0.0)
-3.5 ± 1.8 
(-7.2,0.1)
-1.2 ± 1.5 
(-4.2,1.9)
-2.9 ± 1.5 
(-6.0,0.2)
(n = 7) ACE DD (n = 11)
SBP 10.3 ± 3.3 
(3.1,16.8)
0.5 ± 3.0 
(-5.5,6.5)
7.7 ± 3.5 
(0.6,14.7)
10.0 ± 2.6 
(4.8,15.2)
8.4 ± 2.4 
(3.6,13.2)
2.5 ± 2.8* 
(-3.1,8.1)
DBP -3.9 ± 2.5 
(-8.9,1.1)
-5.2 ± 2.1 
(-9.4,-1.0)
-3.0 ± 2.1 
(-7.2,1.2)
-1.5 ± 2.0 
(-5.5,2.5)
-3.0 ± 1.7 
(-6.4,0.3)
-6.0 ± 1.7* 
(-9.3,-2.6)
ACE I/D = angiotensin converting enzyme insertion deletion polymorphism;
Low = < median dietary calcium intake; High = ≥ median dietary calcium intake;
VO2max = maximal oxygen consumption; SBP = systolic blood pressure; DBP = diastolic blood pressure.
*p < 0.05, † p < 0.01 exercise vs non-exercise control
Table 4: Mean blood pressure change (± SEM) from baseline after exercise andnon-exercise control by AT1R A/C genotype group over 
10 h (95% confidence interval).
Dietary Calcium Intake Level
Low High
Non-Exercise 
Control
40% VO2max 60% VO2max Non-Exercise 
Control
40% VO2max 60% VO2max
(n = 16) AT1RA A (n = 11)
SBP 11.0 ± 2.2 
(6.6,15.4)
5.8 ± 2.1 
(1.5,10.1)
3.5 ± 2.3† 
(-1.2,8.1)
13.8 ± 2.6 
(8.5,19.1)
10.4 ± 2.6 
(5.2,15.6)
6.9 ± 2.8* 
(1.2,12.5)
DBP -1.9 ± 1.6 
(-5.1,1.3)
-3.8 ± 1.4 
(-6.6,-1.0)
-3.5 ± 1.4 
(-6.4,-0.7)
0.9 ± 1.9 
(-2.9,4.7)
-3.4 ± 1.7 
(-6.8,0.0)
-3.1 ± 1.7 
(-6.5,0.3)
(n = 9) AT1R CC/AC (n = 12)
SBP 12.6 ± 2.9 
(6.7,18.5)
5.1 ± 2.8* 
(-0.6,10.8)
10.5 ± 3.1 
(4.2,16.7)
6.0 ± 2.5 
(0.9,11.1)
11.8 ± 2.4 
(6.8,16.7)
4.8 ± 2.7 
(-0.6,10.2)
DBP -1.2 ± 2.1 
(-5.4,3.1)
-4.3 ± 1.9 
(-8.0,-0.6)
-1.3 ± 1.9 
(-5.0,2.5)
-5.2 ± 1.8 
(-8.9,-1.5)
-0.6 ± 1.6 
(-3.8,2.6)
-5.3 ± 1.6 
(-8.6,-2.0)
AT1R A/C = angiotensin II type 1 receptor polymorphism; Low = < median dietary calcium intake; High = ≥ median dietary calcium intake; VO2max 
= maximal oxygen consumption; SBP = systolic blood pressure; DBP = diastolic blood pressure.
*p < 0.05, † p < 0.01 exercise vs non-exercise controlNutrition & Metabolism 2007, 4:1 http://www.nutritionandmetabolism.com/content/4/1/1
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only the SBP response after 40% VO2max differed
between dietary calcium intake levels. Under these condi-
tions, DBP did not differ between dietary calcium intake
levels (Figure 3). The acute SBP lowering effects of aerobic
exercise were further modulated by interactions among
dietary calcium level, exercise intensity and RAS polymor-
phisms.
With LowCa, SBP was lower after 60% VO2max among
those less predisposed to cardiovascular disease risk based
upon RAS genotype, i.e. ACE I allele carriers and AT1R AA
homozygotes; and after 40% VO2max among those more
predisposed to cardiovascular disease risk based upon
their RAS genotype, i.e., ACE DD homozygotes and carri-
ers of the AT1R C allele [17,18]. With HighCa, BP was low-
ered after 60% VO2max among ACE DD and AT1R AA
homozygotes, but not after 40% VO2max. Our findings
with LowCa and RAS polymorphisms reinforce the notion
that lower intensity, aerobic exercise (40% VO2max)
equivalent in physical exertion to leisurely walking is safer
and better tolerated by people with high BP than more
vigorous intensity, aerobic exercise (≥ 60% VO2max) [30].
Thus, lower intensity, aerobic exercise should be pre-
scribed for those with high BP who are at increased risk of
cardiovascular disease due to their dietary habits [8,11,12]
and genetic predisposition [17,18].
Dietary calcium intake [8-13] and the RAS [14-18,31] are
important regulators of BP via their effects on calcium
metabolism. High levels of intracellular calcium increase
vascular smooth muscle tone, peripheral vascular resist-
ance, and responsiveness to the sympathetic and RAS sys-
tems; actions which elevate BP [9-11,32]. Paradoxically it
is low but not high dietary calcium intake that stimulates
an increase in parathyroid hormone leading to calcium
mobilization from bone, increased intestinal calcium
absorption, decreased renal calcium excretion, increased
intracellular calcium concentration, and subsequently
high BP. We found that a session of aerobic exercise inter-
acted favorably with low but not high dietary calcium
intake to lower BP. A possible explanation for these find-
ings is that a bout of aerobic exercise acted on the sodium/
calcium exchanger in vascular smooth muscle cells to
extrude calcium from the intracellular space, thereby
acutely decreasing BP among men with low dietary cal-
cium intake who theoretically would have had the higher
intracellular calcium concentration [31,33,34].
Klar et al. [22] have shown that angiotensin II inhibits
renin gene expression in the kidney, thereby increasing
intracellular calcium concentration. In addition, angi-
otensin II is a powerful signaling molecule that modulates
calcium flux in brain stem nuclei that regulate vascular
resistance via the AT1R [23]. Aerobic exercise activates the
RAS in an intensity dependent manner [21]. The mecha-
nisms by which dietary calcium intake and RAS polymor-
phisms would interact with exercise intensity to modulate
postexercise hypotension are not clear. Nonetheless, our
findings suggest the phenotypic expression of BP resulting
from interactions among dietary calcium intake, exercise
intensity and RAS polymorphisms reside in the balance
achieved among them regarding the sodium/calcium
exchanger in vascular smooth muscle and the general state
of reactivity that they impose on the vasculature
[9,10,16,21,31-36].
The complexity of the relationships we found among die-
tary calcium intake and RAS polymorphisms on postexer-
cise hypotension were unexpected. Due to their
preliminary nature and the small number of men in each
of the designated dietary calcium intake level and RAS
genotype groups, our findings are hypothesis generating.
Of note is that they are consistent with our previous work
on postexercise hypotension documenting exercise inten-
sity [20] and RAS polymorphisms [21] differentially mod-
ulated the BP response to acute aerobic exercise. Our work
continues to provide insight into possible reasons why
25–30% of the people with hypertension do not lower
their BP after exercise [19]; observations that can be par-
tially attributed to the complex interactions among envi-
ronmental (i.e., diet and exercise) and genetic modulators
of BP [6,7].
Other dietary nutrients have been implicated in BP regu-
lation including potassium, magnesium and sodium
[1,10,13,31,35]. Accordingly, we analyzed our findings
for the potentially strong confounding influences of these
micronutrients as well as daily energy intake, body mass
index, waist circumference and age. Inclusion of these
covariates singly into the statistical models did not alter
the associations among dietary calcium intake level, RAS
polymorphisms and the BP response to acute aerobic
exercise. The type of food source of calcium may also have
influenced our results [11] so that we examined our data
for % of total calcium derived from dairy sources and
found no difference in our major BP outcomes.
This study was subject to several limitations. Dietary cal-
cium intake was quantified from multiple 3 d food record
sets in a free living population. However, the degree of
interaction with the same registered dietitian throughout
the study was intensive and assures a certain level of con-
fidence in the dietary data. More importantly, others have
documented that 3 d food records are sufficient to provide
information regarding routine nutrient intake [37]. In
addition, there were no differences noted in total energy,
diet composition and micronutrient intake between the
24 h recall and 3 d food record nutrient analyses. The
small number of subjects in some of the dietary calcium
intake level and RAS genotype groups limit the conclu-Nutrition & Metabolism 2007, 4:1 http://www.nutritionandmetabolism.com/content/4/1/1
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sions that can be made about the interactions of diet and
genetic variation on postexercise hypotension. Nonethe-
less, BP differed within a given dietary calcium level, exer-
cise condition and RAS genotype group as well as between
RAS genotype groups for a given dietary calcium level and
exercise condition, suggesting the BP differences we found
are partially due to genetic variation. Additionally, results
from this study can be generalized only to the subjects
enrolled-white, middle aged and overweight men with
high normal to Stage 1 hypertension who are not taking
medication for their high BP.
Conclusion
The novel findings of this investigation were that the BP
response to acute aerobic exercise was modulated by inter-
actions among dietary calcium intake, exercise intensity
and RAS polymorphisms. Specifically, with LowCa, SBP
was reduced after 60% VO2max among those less predis-
posed to cardiovascular disease risk based upon their RAS
genotype; and after 40% VO2max among those more pre-
disposed to cardiovascular disease risk based upon their
RAS genotype. With HighCa, BP was lower after 60%
VO2max (but not 40% VO2max) among ACE DD and
AT1R AA homozygotes. Interactions among dietary cal-
cium intake, exercise intensity and RAS polymorphisms
provide insight into why most people manifest postexer-
cise hypotension but some do not. Further investigation is
needed to validate our findings in a larger, more ethni-
cally diverse sample of men and women in which dietary
calcium intake is manipulated so that definitive conclu-
sions can be made about the complex relationships we
observed among dietary calcium intake, exercise intensity
and RAS polymorphisms on the immediate BP lowering
effects of aerobic exercise.
Abbreviations
Angiotensin converting enzyme insertion deletion poly-
morphism ACE I/D
Angiotensin II type 1 receptor polymorphism AT1R A/C
Blood Pressure BP
Diastolic blood pressure DBP
HighCa Calcium intake ≥ 880 mg/d
LowCa Calcium intake < 880 mg/d
Maximal oxygen consumption VO2 max
Renin angiotensin system RAS
Systolic blood pressure SBP
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